SOURCE: IDenta Corp.

March 18, 2008 10:00 ET

IDenta Drug & Explosives Detectors Being Evaluated by African Nations Involved in International War on Drugs

JERUSALEM--(Marketwire - March 18, 2008) - IDenta Corp. (PINKSHEETS: IDTA) released a brief statement today concerning the status of negotiations with four governments in Africa. The unnamed countries, located in the western region of the continent, are key ports for international drug cartels in South America seeking to smuggle drugs into Europe.

The statement read:

"We are pleased to inform our shareholders that IDenta Corp. is currently in advanced negotiations with four African governments to begin using IDenta drug detectors to help fight the war on drugs in these very vulnerable environments. IBTEC, the company's representatives in France, are leading the discussions because of the very close, long-term association these countries have with the government of France.

We expect to soon begin announcing the completion of one or more of these agreements, and will disclose further details of their positive impact on the company's operations and revenues at that time."

Last week the company announced that IDenta Alert explosive detectors and IDenta Stinger drug detectors have been officially selected by numerous police and governmental agencies in France. IBTEC was also responsible for leading these negotiations, which have revenues that are projected to exceed one million dollars over the next 12 months for IDTA.

About IDenta

Since 2003, IDenta Corporation has become recognized as a worldwide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets that consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.

Disclaimer

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally, contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com

    For Investor Relations in the US, contact:
    Randy Jacobs
    Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For information about the Accutest® - IDenta products in the US, please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    http://www.accutest.net